IM Cannabis (IMCC) Income from Continuing Operations (2020 - 2026)

IM Cannabis (IMCC) recorded quarterly Income from Continuing Operations of 1858745.31 in Q1 2026, up 67.05% quarter-over-quarter from 5640600.7 in Q4 2025, and down 2379.57% on a YoY basis from 81539.23 in Q1 2025.

IM Cannabis (IMCC) Income from Continuing Operations (2020 - 2026) Analysis & Trends

IM Cannabis' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 1858745.31 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations fell 2379.57% year-over-year to 1858745.31; the TTM figure through Mar 2026 stood at 10447802.52 (down 154.4% YoY), while the FY2025 annual figure was 8425763.83, up 2.0% from the prior year.
  • Income from Continuing Operations was 1858745.31 for Q1 2026 at IM Cannabis, up from 5640600.7 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3162061.52 in Q3 2022 to a low of 31126435.92 in Q4 2022.
  • Historically, Income from Continuing Operations has averaged 4111260.74 across 5 years, with a median of 2526821.73 in 2024.
  • The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations surged 379.57% in 2022, then slumped 2379.57% in 2026.
  • A 5-year view of Income from Continuing Operations shows it stood at 31126435.92 in 2022, then surged by 60.03% to 12440093.69 in 2023, then soared by 93.02% to 868325.01 in 2024, then tumbled by 549.6% to 5640600.7 in 2025, then surged by 67.05% to 1858745.31 in 2026.
  • The last three Income from Continuing Operations figures came in at 1858745.31 (Q1 2026), 5640600.7 (Q4 2025), and 2808444.29 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 IM Cannabis 57,090.22 -728,264.31 1.03 Mn -1.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.86 Mn
Dec 31, 2025 -5.64 Mn
Sep 30, 2025 -2.81 Mn
Jun 30, 2025 -140,012.22
Mar 31, 2025 81,539.23
Dec 31, 2024 -868,325.01
Sep 30, 2024 -793,163.79
Jun 30, 2024 -2.53 Mn
Mar 31, 2024 -4.63 Mn
Dec 31, 2023 -12.44 Mn
Sep 30, 2023 1.59 Mn
Jun 30, 2023 -2.76 Mn
Mar 31, 2023 -640,577.05
Dec 31, 2022 -31.13 Mn
Sep 30, 2022 3.16 Mn
Jun 30, 2022 -2.90 Mn
Mar 31, 2022 -5.59 Mn
Dec 31, 2021 -6.63 Mn
Sep 30, 2021 659,359.73
Jun 30, 2021 -4.14 Mn